Wednesday December 20, 7:59 am Eastern Time
Press Release
SOURCE: Genomic Solutions Inc.
Major Research Organizations Designate Genomic Solutions for Large-Scale Proteomic Research Services
ANN ARBOR, Mich., Dec. 20 /PRNewswire/ -- Genomic Solutions Inc. (Nasdaq: GNSL - news), a leading, worldwide supplier of automated solutions for genomic and proteomic research, announces that several major pharmaceutical, biotechnology and academic organizations have contracted specialized research needs to Genomic Solutions' new Proteomic Research Center. These organizations include Duke University, Durham, North Carolina, and the Josephine Ford Cancer Center, Henry Ford Health System, Detroit, Michigan.
(Photo: newscom.com )
``We are pleased these major research organizations have entrusted major portions of their proteomics research work to our Proteomic Research Center specialists,'' says Michael Pisano, Ph.D., Vice President, Proteomic Research and Development at Genomic Solutions. ``Center personnel possess expertise in all areas of proteomics, from front-end separation to sophisticated mass spectrometry. Our staff scientists are able to provide the necessary protein data to help the researcher identify potential therapeutic targets and/or biomarkers.''
According to Pisano, the 7,000-square-foot facility, located at Genomic Solutions' Ann Arbor, Michigan headquarters, can handle all aspects of proteomics work. Starting with raw tissue samples provided by customers, the Center's labs can accomplish everything from prefractionation through identification of proteins and determination of posttranslational modifications. Because the lab utilizes a high-throughput, automated process, the work can be done very quickly. Automation makes it possible for customers to examine a large number of proteins -- volume that was not possible using previous, manual methods. System automation also makes this a highly reproducible process.
The Center features the latest instrumentation and robotics offered by Genomic Solutions in its ``full circle'' of integrated research tools for high throughput proteomics. Currently, the Center utilizes the complete Investigator(TM) Proteomic System. Genomic Solutions has designed the System to automate and enhance the throughput of proteomic studies.
The System includes 2-D electrophoresis with tube IPG or tube gel option, imager and HT analyzer software; ProPic(TM) excision robot for imaging and picking SYPRO® Ruby stained gels, as well as Coomassie® Blue and Silver stained gels; ProGest(TM) digestion robot and the ProMS(TM) MALDI prep station. The Investigator System works with mass spectrometers from all major manufacturers. The GNSL facility utilizes mass spec units supplied by PEBio/Applied Bio, MicroMass and ThermoQuest.
The Proteomic Research Center also uses Protein Warehouse(TM), Genomic Solutions' proprietary software program that integrates data from each component of the Investigator system.
Genomic Solutions Inc. designs, develops, manufactures, markets and sells instruments, software, consumables and services used to determine the activity level of genes and to isolate, identify and characterize proteins. The company's products and systems enable researchers to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. As a result, Genomic Solutions products and systems facilitate more rapid and less expensive drug discovery. Genomic Solutions markets products through its corporate headquarters in Ann Arbor, Michigan USA, and offices in the United Kingdom and Japan. Remaining worldwide distribution is provided by PerkinElmer Life Sciences through a strategic alliance with Genomic Solutions. The two companies also cooperate to sell co-branded products and collaborate to leverage their intellectual property and technologies. |
